FDA Approved: TAZORAC — Supplemental Application (Almirall, LLC)

View source ↗

Summary

The FDA approved a supplemental application for TAZORAC (tazarotene) filed by Almirall, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Plaque Psoriasis

Drugs mentioned

• TAZORAC (Tazarotene)

Snippet

SUPPL AP for TAZORAC (TAZAROTENE)